REUTERS: The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment, Inrebic, for certain forms of bone marrow cancer.
Bristol-Myers Squibb Co announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology and cardiovascular drugs in the largest pharmaceutical industry merger ever.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Roche's personalized cancer treatment wins FDA approvalThe U.S. Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, the agency said on Thursday.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US FDA proposes graphic warnings on cigarette packs, advertisementsThe U.S. Food and Drug Administration on Thursday proposed new health warnings for cigarette packages and advertisements that it said could be the ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
FDA proposes new health warnings on cigarette packetsThe U.S. Food and Drug Administration on Thursday proposed new health warnings for cigarette packages and advertisements that it said could be the ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US FDA approves TB Alliance's treatment for drug-resistant tuberculosisThe U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug combination ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US FDA approves TB Alliance's treatment for drug-resistant tuberculosisThe U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug combination ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Roche's personalized cancer treatment wins FDA approvalThe U.S. Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, the agency said on Thursday.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »